Digital Interventions for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
Digital mental and behavioral health interventions have potential to significantly improve accessibility for the large number of breast cancer survivors who need treatments. However, the landscape of digital interventions tested in this population remains limited, with the few that have been tested primarily focused on reducing symptoms of mental disorders. This is problematic given the range of psychosocial needs among breast cancer survivors, including those who may not have active mental health symptoms, yet could benefit from learning effective coping skills. Moreover, all of these interventions follow a "one size fits all" approach, lacking precision in terms of when, where, and to whom they should be given. The overarching goals of this project are to develop and pilot a variety of digital micro-interventions (DMIs) for breast cancer survivors - highly focused, technology-enabled interventions that can be delivered in the context of a person's daily life with little burden on the individual.
Are You a Good Fit for This Trial?
This trial is for breast cancer survivors who might benefit from digital interventions to improve their mental health and coping skills. Specific eligibility criteria are not provided, so it's best to contact the study organizers for details on who can participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in digital micro-interventions such as savoring, gratitude, challenging unhelpful thoughts, psychoeducation, behavioral activation, and acceptance
Follow-up
Participants are monitored for satisfaction and acceptability of the digital interventions
What Are the Treatments Tested in This Trial?
Interventions
- Digital Micro-Interventions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Virginia
Lead Sponsor
National Cancer Institute (NCI)
Collaborator